ClinicalTrials.Veeva

Menu

Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ? (ALLIANCE)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Juvenile Idiopathic Arthritis

Study type

Observational

Funder types

Other

Identifiers

NCT02824978
ALLIANCE (RB 16.004 )

Details and patient eligibility

About

to evalute if therapeutic alliance is related to adherence in JIA

Full description

The therapeutic alliance is the agreement that is being built between doctor and patient during the construction process of care. So active collaboration based on a shared assessment of issues and agreement on possible solutions. Initially described in psychiatry, this analytical concept has been extended to several chronic diseases in particular requiring more often a strong link between doctor and patient. His measure is important since it has been demonstrated by several previous studies that the therapeutic alliance is predictive of the therapeutic effects of treatment. This alliance, however, was little studied in juvenile idiopathic arthritis, its connection with the observance or the quality of life has never been evaluated.

The chronic nature of juvenile idiopathic arthritis (JIA) requires a strong ability of the child to follow his treatment, where the role of parents going to be important and where the relationship built with the caregiver is also essential.

Adherence is a complex concept for which there is no ideal measure. Direct evaluation criteria such as bioassays prove still incomplete and difficult to implement in observational studies. Indirect measures have been developed through self-administered questionnaires and literature showed their relatively good correlation with actual catches. The innovative hypothesis of this research is that a better therapeutic alliance is associated with better adherence child in JIA.

Enrollment

120 patients

Sex

All

Ages

8 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with JIA (see classification above)
  • Aged at least 8 to 18 years.
  • Having already seen more than 2 times in consultation with the referring physician will even include the child in the study so that the alliance could build process
  • Children can read, understand and complete questionnaires
  • No opposition made

Exclusion criteria

  • Systemic form of JIA;
  • Children aged under 8 years old or over 18 years;
  • Child or parent does not understand French
  • Refusal of participation

Trial contacts and locations

17

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems